Search result for 'alzheimer\'s'

Eli Lilly to invest USD 1 billion in India to scale up contract manufacturing and establish a new hub in Hyderabad.

Biogen is halting development and sales of its controversial Alzheimer's drug Aduhelm, focusing instead on other treatments like Leqembi. The drug faced challenges due to weak evidence and limited...